Food & Drug Administration (FDA) announced it will convene the Pharmacy Compounding Advisory Committee (PCAC) on July 23 and 24, 2026, to discuss permitting compounding pharmacies to prepare certain peptides used for ulcerative colitis (UC), wound healing, obesity, insomnia, opioid withdrawal, inflammatory conditions, and osteoporosis, among other conditions
The FDA classified BPC-157 as Category 2 based on insufficient safety data combined with mechanistic concerns
Hartman 2015)
However, in the TER group (i.e., tumor-bearing mice receiving both exercise and RSV), mTORC1 phosphorylation was markedly increased compared to the TSV, TEV, and TSR groups, demonstrating the synergistic restoration of anabolic signaling (88)